What is the current Price Target for the Vaxcyte Inc stock?

The average Vaxcyte Inc target price is $150.22. This is 102.40% higher than the current stock price. The highest price target is 119.62%, the lowest is 81.89%. 9 Analysts have issued a price target Vaxcyte Inc 2026 .

How high will the Vaxcyte Inc stock rise?

No reliable answer can be given as to how high the Vaxcyte Inc stock will rise. The performance of stocks, including the Vaxcyte Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Vaxcyte Inc stock today?

The performance of Vaxcyte Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Vaxcyte Inc stock fall?

The decline in Vaxcyte Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Vaxcyte Inc Forecast, price target & analysts

$70.58

4.90% today

Nasdaq, Feb 28, 08:19 pm CET

ISIN

US92243G1085

Symbol

PCVX

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Vaxcyte Inc Target price 2025 - Analyst rating & recommendation

Vaxcyte Inc Classifications & Recommendation:

Buy

100%

Vaxcyte Inc Price Target

Target Price	$150.22
Price	$74.22
Potential	102.40% register free of charge
Number of Estimates	9

	9 Analysts have issued a price target Vaxcyte Inc 2026 . The average Vaxcyte Inc target price is $150.22. This is 102.40% register free of charge higher than the current stock price. The highest price target is $163.00 119.62% register free of charge , the lowest is $135.00 81.89% register free of charge .
	A rating was issued by 9 analysts: 9 Analysts recommend Vaxcyte Inc to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Vaxcyte Inc stock has an average upside potential 2026 of 102.40% register free of charge . Most analysts recommend the Vaxcyte Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-3.80	-4.64
	8.21%	22.11%
P/E		negative

4 Analysts have issued a Vaxcyte Inc forecast for earnings per share. The average Vaxcyte Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-3.80	8.21%
2025	$-4.64 22.11% Unlock
2026	$-3.86 16.81% Unlock
2027	$-2.84 26.42% Unlock
2028	$-1.25 55.99% Unlock
2029	$2.95 336.00% Unlock

Current	-19.13	16.93%
2025	-16.00 16.36% Unlock
2026	-19.23 20.19% Unlock
2027	-26.18 36.14% Unlock
2028	-59.38 126.81% Unlock
2029	25.16 142.37% Unlock

Vaxcyte Inc...

Current Vaxcyte Inc Upgrades & Downgrades Beta

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Needham	Locked ➜ Locked	Locked	Feb 26 2025
Guggenheim	Locked ➜ Locked	Locked	Feb 26 2025
Needham	Locked ➜ Locked	Locked	Feb 11 2025
Goldman Sachs	Locked ➜ Locked	Locked	Dec 20 2024
Cantor Fitzgerald	Locked ➜ Locked	Locked	Nov 06 2024
Needham	Locked ➜ Locked	Locked	Nov 06 2024
Mizuho	Locked ➜ Locked	Locked	Sep 10 2024

Analyst Rating	Date
Locked Needham: Locked ➜ Locked	Feb 26 2025
Locked Guggenheim: Locked ➜ Locked	Feb 26 2025
Locked Needham: Locked ➜ Locked	Feb 11 2025
Locked Goldman Sachs: Locked ➜ Locked	Dec 20 2024
Locked Cantor Fitzgerald: Locked ➜ Locked	Nov 06 2024
Locked Needham: Locked ➜ Locked	Nov 06 2024
Locked Mizuho: Locked ➜ Locked	Sep 10 2024

Discover more stocks with a high price target

Coinbase Global, Inc. 60.51%

BioNTech SE - ADR 30.07%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now